Basic Information
Basic information for SNHG14-231-23aa-1
Peptide Name SNHG14-231-23aa-1
Genome Position chr15:25074010-25074051,25075735-25075761[+]
Species Human
Peptide Sequence MVWAPLEAFGFLLNVALVWKEGQ
Peptide Length 23
Unique No (SNHG14-210-23aa-5,SNHG14-224-23aa-3,SNHG14-227-23aa,SNHG14-235-23aa-1,SNHG14-248-23aa-3,SNHG14-254-23aa,SNHG14-269-23aa-2,SNHG14-272-23aa-2,SNHG14-282-23aa-1,SNHG14-290-23aa-1,SNHG14-291-23aa-3,SNHG14-299-23aa,SNHG14-304-23aa-1,SNHG14-305-23aa-1,SNHG14-309-23aa-3,SNHG14-313-23aa,SNHG14-318-23aa-1,SNHG14-319-23aa-2,SNHG14-323-23aa-3,SNHG14-332-23aa-2,SNHG14-333-23aa,SNHG14-340-23aa-1)
Grand Average of Hydropathicity 0.8087
Relative Molecular Mass 3015.42
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000224078;SNHG14
Transcript ID/Name ENST00000654223;SNHG14-231
Transcript Length 9815
Coding Ability 0.4435
DNA Sequence Corresponding to Peptide ATGGTGTGGGCTCCTTTGGAGGCTTTTGGATTTCTCCTGAATGTGGCGTTGGTATGGAAGGAAGGCCAG
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :